Explain this page
Arphra AIPlain-English read on Labcorp Holdings Inc.’s valuationAI Issuer Brief
Arphra AILoading cached brief…
Peers
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.47% | -1.41% | +2.34% | -7.81% | -0.98% | +3.20% | +1.79% | +38.39% | +13.16% | +131.88% | +1136.49% |
Aftermarket
LiveLast trade
$259.51
88 sh
Bid
$251.19
4 sh
Ask
$288.00
1 sh
Spread
$36.810
Sector & industry today
LiveSectors
- Healthcare+1.32%
- Financial Services+1.14%
- Industrials+0.68%
- Consumer Cyclical+0.59%
- Energy+0.52%
- Real Estate+0.46%
- Consumer Defensive+0.12%
- Basic Materials-0.28%
- Utilities-1.42%
- Communication Services-1.84%
- Technology-2.36%
Top industries (issuer's industry highlighted)
- Medical - Diagnostics & Research+0.87%
- Rental & Leasing Services+5.32%
- Financial - Mortgages-4.41%
- Broadcasting-4.23%
- Investment - Banking & Investment Services-4.21%
- Software - Application-4.13%
- Auto - Recreational Vehicles+4.13%
- Software - Infrastructure-3.47%
- Information Technology Services-3.40%
- Department Stores+3.03%
- Silver-3.02%
- Apparel - Retail+2.95%
Fair value
Football field →Weighted blend
$502.68
+94.15% vs spot
Recommendation
Strong Buy
18 of 19 methods
Method spread
8bull8bear
±5% threshold
Analyst PT consensus: $311.33 (+20.24%)
Total assets
$18.39B
Total debt
$7.2B
Cash & equiv
$532.3M
Operating CF
$1.64B
Free cash flow
$1.21B
Buybacks
-$450M
Analyst view
DB · price_targets + analyst_gradesConsensus target
$311.33
+20.24% upside
Low
$300.00
Median
$300.00
High
$334.00
Recent actions
0 ↑0 ↓8 hold
- May 01, 2026
- Apr 01, 2026
- Mar 01, 2026
- Feb 01, 2026
- Jan 01, 2026
News
DB · news_items- Labcorp Holdings Inc. (LH) Presents at Jefferies Global Healthcare Conference 2026 Transcriptseekingalpha.com·Jun 03, 2026
- Labcorp and Epic Expand Collaboration to Advance Diagnostic Integration across Hospitals and Health Systemsprnewswire.com·May 12, 2026
- Labcorp and Epic Expand Collaboration to Advance Diagnostic Integration across Hospitals and Health Systemsprnewswire.com·May 12, 2026
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q1 Mar 2026 | $3.54B | $277.8M | $3.35 |
| Q4 Dec 2025 | $3.52B | $164.7M | $1.98 |
| Q3 Sep 2025 | $3.56B | $261.1M | $3.12 |
| Q2 Jun 2025 | $3.53B | $237.9M | $2.84 |
| Q1 Mar 2025 | $3.35B | $212.8M | $2.52 |
| Q4 Dec 2024 | $3.33B | $143.4M | $1.70 |
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
Meltzer Jonathan C officer: EVP, Operations | Sell | 839 | $224.05K | Mar 27, 2026 |
Wilkinson Peter J officer: SVP, Chief Accounting Officer | Sell | 1,633 | $436.09K | Mar 27, 2026 |
Schechter Adam H director, officer: President & CEO | Sell | 8,705 | $2.44M | Mar 03, 2026 |
van der Vaart Sandra D officer: EVP, Corporate Affairs | Sell | 548 | $156K | Feb 27, 2026 |
Caveney Brian J officer: EVP, Pres of ED, CMO & CSO | Sell | 1,500 | $429.46K | Feb 24, 2026 |
Wilkinson Peter J officer: SVP, Chief Accounting Officer | Sell | 666 | $185.11K | Feb 19, 2026 |
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|---|---|---|---|---|
| FY 2025 | $13.95B | $1.52B | $876.5M | $10.46 | +6.28% |
| FY 2024 | $13.01B | $1.09B | $746M | $8.84 | +5.73% |
| FY 2023 | $12.16B | $725.6M | $418M | $4.77 | +3.44% |
| FY 2022 | $11.86B | $1.44B | $1.28B | $13.96 | +10.78% |
| FY 2021 | $13.14B | $3.05B | $2.38B | $24.38 | +18.10% |